DE60141083D1 - Leptin zur behandlung des respiratory-distress-syndroms und verminderter lungen surfactant-produktion - Google Patents

Leptin zur behandlung des respiratory-distress-syndroms und verminderter lungen surfactant-produktion

Info

Publication number
DE60141083D1
DE60141083D1 DE60141083T DE60141083T DE60141083D1 DE 60141083 D1 DE60141083 D1 DE 60141083D1 DE 60141083 T DE60141083 T DE 60141083T DE 60141083 T DE60141083 T DE 60141083T DE 60141083 D1 DE60141083 D1 DE 60141083D1
Authority
DE
Germany
Prior art keywords
treatment
leptin
surfactant production
respiratory distress
distress syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60141083T
Other languages
English (en)
Inventor
Vicky L Funanage
Sandra G Hassink
Susan M Kirwin
Darlise Connor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nemours Foundation
Original Assignee
Nemours Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nemours Foundation filed Critical Nemours Foundation
Application granted granted Critical
Publication of DE60141083D1 publication Critical patent/DE60141083D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fluid-Pressure Circuits (AREA)
  • Medicinal Preparation (AREA)
DE60141083T 2000-11-14 2001-11-13 Leptin zur behandlung des respiratory-distress-syndroms und verminderter lungen surfactant-produktion Expired - Lifetime DE60141083D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/711,295 US6884777B1 (en) 2000-11-14 2000-11-14 Method for treating respiratory distress syndrome
PCT/US2001/043069 WO2002062289A2 (en) 2000-11-14 2001-11-13 Method for treating respiratory distress syndrome

Publications (1)

Publication Number Publication Date
DE60141083D1 true DE60141083D1 (de) 2010-03-04

Family

ID=24857494

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60141083T Expired - Lifetime DE60141083D1 (de) 2000-11-14 2001-11-13 Leptin zur behandlung des respiratory-distress-syndroms und verminderter lungen surfactant-produktion

Country Status (7)

Country Link
US (2) US6884777B1 (de)
EP (1) EP1341550B1 (de)
AT (1) ATE454899T1 (de)
AU (1) AU2001297652A1 (de)
CA (1) CA2428937C (de)
DE (1) DE60141083D1 (de)
WO (1) WO2002062289A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475984B2 (en) * 1999-04-29 2002-11-05 The Nemours Foundation Administration of leptin
US6884777B1 (en) * 2000-11-14 2005-04-26 The Nemours Foundation Method for treating respiratory distress syndrome
AU2006203978B2 (en) * 2005-01-06 2011-11-03 Discovery Laboratories, Inc. Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia
ES2258923B1 (es) * 2005-02-23 2007-11-01 Universitat De Les Illes Balears Uso de la leptina para la prevencion del exceso de peso corporal y composicion que contiene leptina.
RU2523573C1 (ru) * 2013-04-23 2014-07-20 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский институт акушерства и педиатрии" Министерства здравоохранения Российской Федерации Способ лечения респираторного дистресс-синдрома новорожденных, находящихся на ивл
WO2014193597A1 (en) * 2013-05-02 2014-12-04 University Of Vermont And State Agricultural College Leptin for treating systemic inflammatory response syndrome

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048837A (en) * 1994-08-17 2000-04-11 The Rockefeller University OB polypeptides as modulators of body weight
US5552523A (en) 1995-01-31 1996-09-03 Eli Lilly And Company Anti-obesity proteins
US5552524A (en) 1995-01-31 1996-09-03 Eli Lilly And Company Anti-obesity proteins
US5521283A (en) 1995-01-31 1996-05-28 Eli Lilly And Company Anti-obesity proteins
US5552522A (en) 1995-01-31 1996-09-03 Eli Lilly And Company Anti-obesity proteins
US5773416A (en) 1995-10-25 1998-06-30 The Regents Of The University Of California Methods for restoring or enhancing reproductive function in reproductively impaired hosts
US6022737A (en) 1995-11-02 2000-02-08 Amgen Inc. Formulations for non-viral in vivo transfection in the lungs
US5891717A (en) 1996-01-19 1999-04-06 Betagene, Inc. Methods and compositions for inhibiting hexokinase
US5854067A (en) 1996-01-19 1998-12-29 Board Of Regents, The University Of Texas System Hexokinase inhibitors
US6020382A (en) 1996-02-02 2000-02-01 Merck & Co., Inc. Method of treating diabetes and related disease states
US5847008A (en) 1996-02-02 1998-12-08 Merck & Co., Inc. Method of treating diabetes and related disease states
US5859051A (en) 1996-02-02 1999-01-12 Merck & Co., Inc. Antidiabetic agents
US5866341A (en) 1996-04-03 1999-02-02 Chugai Pharmaceutical Co., Ltd. Compositions and methods for screening drug libraries
US5728728A (en) 1996-04-10 1998-03-17 Kozachuk; Walter E. Methods of providing neuroprotection
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
GB9726851D0 (en) 1997-12-19 1998-02-18 Zeneca Ltd Human signal transduction serine/threonine kinase
US6475984B2 (en) * 1999-04-29 2002-11-05 The Nemours Foundation Administration of leptin
US6630444B1 (en) * 2000-10-23 2003-10-07 The Nemours Foundation Intestinal function using leptin
US6884777B1 (en) * 2000-11-14 2005-04-26 The Nemours Foundation Method for treating respiratory distress syndrome

Also Published As

Publication number Publication date
AU2001297652A1 (en) 2002-08-19
CA2428937A1 (en) 2002-08-15
US6884777B1 (en) 2005-04-26
ATE454899T1 (de) 2010-01-15
CA2428937C (en) 2011-01-25
EP1341550B1 (de) 2010-01-13
EP1341550A4 (de) 2004-07-07
WO2002062289A2 (en) 2002-08-15
US20060084601A1 (en) 2006-04-20
WO2002062289A3 (en) 2002-11-28
EP1341550A2 (de) 2003-09-10

Similar Documents

Publication Publication Date Title
DE60231804D1 (de) Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomöostase störungen
HUP0300299A2 (hu) Szabad aminosavakat tartalmazó kompozíció
DE60139554D1 (de) Probiotika zur primären prävention atopischer erkrankungen
ATE324110T1 (de) Stoffe mit serotoninartiger wirkung zur behandlung der schlafapnoe
DE60213861D1 (de) Orodispergierbare tabletten mit fexofenadin
ATE417606T1 (de) Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege
MY145410A (en) Method for preventing or treating respiratory infections and acute otitis media in infants
ATE325612T1 (de) Verwendung von hydroxyethylrutosiden zur behandlung von erkältungssymptomen, symptomen der allergischen rhinitis und atemwegsinfektionen
DE69130682T2 (de) Nikotinundurchlässiger behälter sowie verfahren zur herstellung desselben
DE602005024571D1 (de) Opioide zur behandlung von ruhelosigkeit in den unteren gliedmassen
DE60202477D1 (de) Vorrichtung zur verabreichung einer substanz
HUP0401501A2 (hu) Érrendszeri gyulladás kezelése vagy megelőzése szterin-felszívódást gátló anyagokat tartalmazó gyógyszerkészítmények alkalmazásával
ATE447403T1 (de) Cannabinoiden zur behandlung von während des schlafens auftretenden atmungsstörungen
DE60017801D1 (de) Inhalierung von antiendotoxinmitteln zur vorbeugung oder behandlung von bakterieller lungeninfektion oder symptomatischer endotoxinaussetzung der lunge
DE50109156D1 (de) Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd
DE60141083D1 (de) Leptin zur behandlung des respiratory-distress-syndroms und verminderter lungen surfactant-produktion
HUP0304050A2 (hu) Módosított FVII az ARDS kezelésre
ATE244008T1 (de) Verwendung von makroliden zur behandlung von akuten lungenverletzungen
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
NO20032597D0 (no) Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma
EE200200404A (et) Kaltsiumdikarboksülaateetrid, nende valmistamismeetodid ja vaskulaarse haiguse ning suhkurtõve ravimine nendega
ATE306271T1 (de) Kombination von loteprednol und beta2- adrenozeptor-agonisten und ihre verwendung durch inhalation zur behandlung von asthma bronchiale
ATE386513T1 (de) Verwendung von angelicin und seiner strukturellen analoga zur behandlung von thalassämie
DE602004007304D1 (de) Verwendung von N2O zur Behandlung von postischemischen cerebralen zellulären Beschädigungen
IS2037B (is) Útskiptir beta-díketónar og notkun þeirra

Legal Events

Date Code Title Description
8364 No opposition during term of opposition